“Serum Interleukin-6 Is Associated With Hypocalcemia, Hypoferritinemia and Hyperkalemia in End-Stage Renal Disease Patients”. Italian Journal of Medicine, vol. 16, no. 1, Dec. 2022, https://doi.org/10.4081/itjm.2022.1550.